Global Human Immune Globulin Intravenous Market Growth 2024-2031

Report ID: 1358432 | Published Date: Jan 2025 | No. of Page: 102 | Base Year: 2024 | Rating: 4.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Human Immune Globulin Intravenous Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Human Immune Globulin Intravenous by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Human Immune Globulin Intravenous by Country/Region, 2017, 2022 & 2028
    2.2 Human Immune Globulin Intravenous Segment by Type
        2.2.1 IVIg Liquid
        2.2.2 IVIg Powder
    2.3 Human Immune Globulin Intravenous Sales by Type
        2.3.1 Global Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)
        2.3.2 Global Human Immune Globulin Intravenous Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Human Immune Globulin Intravenous Sale Price by Type (2017-2022)
    2.4 Human Immune Globulin Intravenous Segment by Application
        2.4.1 Immunodeficiency
        2.4.2 Autoimmune Disease
        2.4.3 Acute Infection
    2.5 Human Immune Globulin Intravenous Sales by Application
        2.5.1 Global Human Immune Globulin Intravenous Sale Market Share by Application (2017-2022)
        2.5.2 Global Human Immune Globulin Intravenous Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Human Immune Globulin Intravenous Sale Price by Application (2017-2022)
3 Global Human Immune Globulin Intravenous by Company
    3.1 Global Human Immune Globulin Intravenous Breakdown Data by Company
        3.1.1 Global Human Immune Globulin Intravenous Annual Sales by Company (2020-2022)
        3.1.2 Global Human Immune Globulin Intravenous Sales Market Share by Company (2020-2022)
    3.2 Global Human Immune Globulin Intravenous Annual Revenue by Company (2020-2022)
        3.2.1 Global Human Immune Globulin Intravenous Revenue by Company (2020-2022)
        3.2.2 Global Human Immune Globulin Intravenous Revenue Market Share by Company (2020-2022)
    3.3 Global Human Immune Globulin Intravenous Sale Price by Company
    3.4 Key Manufacturers Human Immune Globulin Intravenous Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Human Immune Globulin Intravenous Product Location Distribution
        3.4.2 Players Human Immune Globulin Intravenous Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Human Immune Globulin Intravenous by Geographic Region
    4.1 World Historic Human Immune Globulin Intravenous Market Size by Geographic Region (2017-2022)
        4.1.1 Global Human Immune Globulin Intravenous Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Human Immune Globulin Intravenous Annual Revenue by Geographic Region
    4.2 World Historic Human Immune Globulin Intravenous Market Size by Country/Region (2017-2022)
        4.2.1 Global Human Immune Globulin Intravenous Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Human Immune Globulin Intravenous Annual Revenue by Country/Region
    4.3 Americas Human Immune Globulin Intravenous Sales Growth
    4.4 APAC Human Immune Globulin Intravenous Sales Growth
    4.5 Europe Human Immune Globulin Intravenous Sales Growth
    4.6 Middle East & Africa Human Immune Globulin Intravenous Sales Growth
5 Americas
    5.1 Americas Human Immune Globulin Intravenous Sales by Country
        5.1.1 Americas Human Immune Globulin Intravenous Sales by Country (2017-2022)
        5.1.2 Americas Human Immune Globulin Intravenous Revenue by Country (2017-2022)
    5.2 Americas Human Immune Globulin Intravenous Sales by Type
    5.3 Americas Human Immune Globulin Intravenous Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Human Immune Globulin Intravenous Sales by Region
        6.1.1 APAC Human Immune Globulin Intravenous Sales by Region (2017-2022)
        6.1.2 APAC Human Immune Globulin Intravenous Revenue by Region (2017-2022)
    6.2 APAC Human Immune Globulin Intravenous Sales by Type
    6.3 APAC Human Immune Globulin Intravenous Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Human Immune Globulin Intravenous by Country
        7.1.1 Europe Human Immune Globulin Intravenous Sales by Country (2017-2022)
        7.1.2 Europe Human Immune Globulin Intravenous Revenue by Country (2017-2022)
    7.2 Europe Human Immune Globulin Intravenous Sales by Type
    7.3 Europe Human Immune Globulin Intravenous Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Human Immune Globulin Intravenous by Country
        8.1.1 Middle East & Africa Human Immune Globulin Intravenous Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Human Immune Globulin Intravenous Revenue by Country (2017-2022)
    8.2 Middle East & Africa Human Immune Globulin Intravenous Sales by Type
    8.3 Middle East & Africa Human Immune Globulin Intravenous Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Human Immune Globulin Intravenous
    10.3 Manufacturing Process Analysis of Human Immune Globulin Intravenous
    10.4 Industry Chain Structure of Human Immune Globulin Intravenous
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Human Immune Globulin Intravenous Distributors
    11.3 Human Immune Globulin Intravenous Customer
12 World Forecast Review for Human Immune Globulin Intravenous by Geographic Region
    12.1 Global Human Immune Globulin Intravenous Market Size Forecast by Region
        12.1.1 Global Human Immune Globulin Intravenous Forecast by Region (2023-2028)
        12.1.2 Global Human Immune Globulin Intravenous Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Human Immune Globulin Intravenous Forecast by Type
    12.7 Global Human Immune Globulin Intravenous Forecast by Application
13 Key Players Analysis
    13.1 Takeda
        13.1.1 Takeda Company Information
        13.1.2 Takeda Human Immune Globulin Intravenous Product Offered
        13.1.3 Takeda Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Takeda Main Business Overview
        13.1.5 Takeda Latest Developments
    13.2 Grifols
        13.2.1 Grifols Company Information
        13.2.2 Grifols Human Immune Globulin Intravenous Product Offered
        13.2.3 Grifols Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Grifols Main Business Overview
        13.2.5 Grifols Latest Developments
    13.3 CSL
        13.3.1 CSL Company Information
        13.3.2 CSL Human Immune Globulin Intravenous Product Offered
        13.3.3 CSL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 CSL Main Business Overview
        13.3.5 CSL Latest Developments
    13.4 Octapharma
        13.4.1 Octapharma Company Information
        13.4.2 Octapharma Human Immune Globulin Intravenous Product Offered
        13.4.3 Octapharma Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Octapharma Main Business Overview
        13.4.5 Octapharma Latest Developments
    13.5 Biotest
        13.5.1 Biotest Company Information
        13.5.2 Biotest Human Immune Globulin Intravenous Product Offered
        13.5.3 Biotest Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Biotest Main Business Overview
        13.5.5 Biotest Latest Developments
    13.6 Kedrion
        13.6.1 Kedrion Company Information
        13.6.2 Kedrion Human Immune Globulin Intravenous Product Offered
        13.6.3 Kedrion Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Kedrion Main Business Overview
        13.6.5 Kedrion Latest Developments
    13.7 Hualan Bio
        13.7.1 Hualan Bio Company Information
        13.7.2 Hualan Bio Human Immune Globulin Intravenous Product Offered
        13.7.3 Hualan Bio Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Hualan Bio Main Business Overview
        13.7.5 Hualan Bio Latest Developments
    13.8 CNBG
        13.8.1 CNBG Company Information
        13.8.2 CNBG Human Immune Globulin Intravenous Product Offered
        13.8.3 CNBG Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 CNBG Main Business Overview
        13.8.5 CNBG Latest Developments
    13.9 Shanghai RAAS
        13.9.1 Shanghai RAAS Company Information
        13.9.2 Shanghai RAAS Human Immune Globulin Intravenous Product Offered
        13.9.3 Shanghai RAAS Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Shanghai RAAS Main Business Overview
        13.9.5 Shanghai RAAS Latest Developments
    13.10 CBPO
        13.10.1 CBPO Company Information
        13.10.2 CBPO Human Immune Globulin Intravenous Product Offered
        13.10.3 CBPO Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 CBPO Main Business Overview
        13.10.5 CBPO Latest Developments
    13.11 LFB Group
        13.11.1 LFB Group Company Information
        13.11.2 LFB Group Human Immune Globulin Intravenous Product Offered
        13.11.3 LFB Group Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 LFB Group Main Business Overview
        13.11.5 LFB Group Latest Developments
    13.12 BPL
        13.12.1 BPL Company Information
        13.12.2 BPL Human Immune Globulin Intravenous Product Offered
        13.12.3 BPL Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 BPL Main Business Overview
        13.12.5 BPL Latest Developments
    13.13 Sichuan Yuanda Shuyang
        13.13.1 Sichuan Yuanda Shuyang Company Information
        13.13.2 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Offered
        13.13.3 Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Sichuan Yuanda Shuyang Main Business Overview
        13.13.5 Sichuan Yuanda Shuyang Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Human Immune Globulin Intravenous Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Human Immune Globulin Intravenous Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of IVIg Liquid
    Table 4. Major Players of IVIg Powder
    Table 5. Global Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
    Table 6. Global Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)
    Table 7. Global Human Immune Globulin Intravenous Revenue by Type (2017-2022) & ($ million)
    Table 8. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2017-2022)
    Table 9. Global Human Immune Globulin Intravenous Sale Price by Type (2017-2022) & (USD/Unit)
    Table 10. Global Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
    Table 11. Global Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)
    Table 12. Global Human Immune Globulin Intravenous Revenue by Application (2017-2022)
    Table 13. Global Human Immune Globulin Intravenous Revenue Market Share by Application (2017-2022)
    Table 14. Global Human Immune Globulin Intravenous Sale Price by Application (2017-2022) & (USD/Unit)
    Table 15. Global Human Immune Globulin Intravenous Sales by Company (2020-2022) & (K Units)
    Table 16. Global Human Immune Globulin Intravenous Sales Market Share by Company (2020-2022)
    Table 17. Global Human Immune Globulin Intravenous Revenue by Company (2020-2022) ($ Millions)
    Table 18. Global Human Immune Globulin Intravenous Revenue Market Share by Company (2020-2022)
    Table 19. Global Human Immune Globulin Intravenous Sale Price by Company (2020-2022) & (USD/Unit)
    Table 20. Key Manufacturers Human Immune Globulin Intravenous Producing Area Distribution and Sales Area
    Table 21. Players Human Immune Globulin Intravenous Products Offered
    Table 22. Human Immune Globulin Intravenous Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 23. New Products and Potential Entrants
    Table 24. Mergers & Acquisitions, Expansion
    Table 25. Global Human Immune Globulin Intravenous Sales by Geographic Region (2017-2022) & (K Units)
    Table 26. Global Human Immune Globulin Intravenous Sales Market Share Geographic Region (2017-2022)
    Table 27. Global Human Immune Globulin Intravenous Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 28. Global Human Immune Globulin Intravenous Revenue Market Share by Geographic Region (2017-2022)
    Table 29. Global Human Immune Globulin Intravenous Sales by Country/Region (2017-2022) & (K Units)
    Table 30. Global Human Immune Globulin Intravenous Sales Market Share by Country/Region (2017-2022)
    Table 31. Global Human Immune Globulin Intravenous Revenue by Country/Region (2017-2022) & ($ millions)
    Table 32. Global Human Immune Globulin Intravenous Revenue Market Share by Country/Region (2017-2022)
    Table 33. Americas Human Immune Globulin Intravenous Sales by Country (2017-2022) & (K Units)
    Table 34. Americas Human Immune Globulin Intravenous Sales Market Share by Country (2017-2022)
    Table 35. Americas Human Immune Globulin Intravenous Revenue by Country (2017-2022) & ($ Millions)
    Table 36. Americas Human Immune Globulin Intravenous Revenue Market Share by Country (2017-2022)
    Table 37. Americas Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
    Table 38. Americas Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)
    Table 39. Americas Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
    Table 40. Americas Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)
    Table 41. APAC Human Immune Globulin Intravenous Sales by Region (2017-2022) & (K Units)
    Table 42. APAC Human Immune Globulin Intravenous Sales Market Share by Region (2017-2022)
    Table 43. APAC Human Immune Globulin Intravenous Revenue by Region (2017-2022) & ($ Millions)
    Table 44. APAC Human Immune Globulin Intravenous Revenue Market Share by Region (2017-2022)
    Table 45. APAC Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
    Table 46. APAC Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)
    Table 47. APAC Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
    Table 48. APAC Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)
    Table 49. Europe Human Immune Globulin Intravenous Sales by Country (2017-2022) & (K Units)
    Table 50. Europe Human Immune Globulin Intravenous Sales Market Share by Country (2017-2022)
    Table 51. Europe Human Immune Globulin Intravenous Revenue by Country (2017-2022) & ($ Millions)
    Table 52. Europe Human Immune Globulin Intravenous Revenue Market Share by Country (2017-2022)
    Table 53. Europe Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
    Table 54. Europe Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)
    Table 55. Europe Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
    Table 56. Europe Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)
    Table 57. Middle East & Africa Human Immune Globulin Intravenous Sales by Country (2017-2022) & (K Units)
    Table 58. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Country (2017-2022)
    Table 59. Middle East & Africa Human Immune Globulin Intravenous Revenue by Country (2017-2022) & ($ Millions)
    Table 60. Middle East & Africa Human Immune Globulin Intravenous Revenue Market Share by Country (2017-2022)
    Table 61. Middle East & Africa Human Immune Globulin Intravenous Sales by Type (2017-2022) & (K Units)
    Table 62. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Type (2017-2022)
    Table 63. Middle East & Africa Human Immune Globulin Intravenous Sales by Application (2017-2022) & (K Units)
    Table 64. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)
    Table 65. Key Market Drivers & Growth Opportunities of Human Immune Globulin Intravenous
    Table 66. Key Market Challenges & Risks of Human Immune Globulin Intravenous
    Table 67. Key Industry Trends of Human Immune Globulin Intravenous
    Table 68. Human Immune Globulin Intravenous Raw Material
    Table 69. Key Suppliers of Raw Materials
    Table 70. Human Immune Globulin Intravenous Distributors List
    Table 71. Human Immune Globulin Intravenous Customer List
    Table 72. Global Human Immune Globulin Intravenous Sales Forecast by Region (2023-2028) & (K Units)
    Table 73. Global Human Immune Globulin Intravenous Sales Market Forecast by Region
    Table 74. Global Human Immune Globulin Intravenous Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 75. Global Human Immune Globulin Intravenous Revenue Market Share Forecast by Region (2023-2028)
    Table 76. Americas Human Immune Globulin Intravenous Sales Forecast by Country (2023-2028) & (K Units)
    Table 77. Americas Human Immune Globulin Intravenous Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 78. APAC Human Immune Globulin Intravenous Sales Forecast by Region (2023-2028) & (K Units)
    Table 79. APAC Human Immune Globulin Intravenous Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 80. Europe Human Immune Globulin Intravenous Sales Forecast by Country (2023-2028) & (K Units)
    Table 81. Europe Human Immune Globulin Intravenous Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 82. Middle East & Africa Human Immune Globulin Intravenous Sales Forecast by Country (2023-2028) & (K Units)
    Table 83. Middle East & Africa Human Immune Globulin Intravenous Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 84. Global Human Immune Globulin Intravenous Sales Forecast by Type (2023-2028) & (K Units)
    Table 85. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Type (2023-2028)
    Table 86. Global Human Immune Globulin Intravenous Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 87. Global Human Immune Globulin Intravenous Revenue Market Share Forecast by Type (2023-2028)
    Table 88. Global Human Immune Globulin Intravenous Sales Forecast by Application (2023-2028) & (K Units)
    Table 89. Global Human Immune Globulin Intravenous Sales Market Share Forecast by Application (2023-2028)
    Table 90. Global Human Immune Globulin Intravenous Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 91. Global Human Immune Globulin Intravenous Revenue Market Share Forecast by Application (2023-2028)
    Table 92. Takeda Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 93. Takeda Human Immune Globulin Intravenous Product Offered
    Table 94. Takeda Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 95. Takeda Main Business
    Table 96. Takeda Latest Developments
    Table 97. Grifols Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 98. Grifols Human Immune Globulin Intravenous Product Offered
    Table 99. Grifols Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 100. Grifols Main Business
    Table 101. Grifols Latest Developments
    Table 102. CSL Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 103. CSL Human Immune Globulin Intravenous Product Offered
    Table 104. CSL Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 105. CSL Main Business
    Table 106. CSL Latest Developments
    Table 107. Octapharma Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 108. Octapharma Human Immune Globulin Intravenous Product Offered
    Table 109. Octapharma Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 110. Octapharma Main Business
    Table 111. Octapharma Latest Developments
    Table 112. Biotest Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 113. Biotest Human Immune Globulin Intravenous Product Offered
    Table 114. Biotest Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 115. Biotest Main Business
    Table 116. Biotest Latest Developments
    Table 117. Kedrion Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 118. Kedrion Human Immune Globulin Intravenous Product Offered
    Table 119. Kedrion Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 120. Kedrion Main Business
    Table 121. Kedrion Latest Developments
    Table 122. Hualan Bio Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 123. Hualan Bio Human Immune Globulin Intravenous Product Offered
    Table 124. Hualan Bio Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 125. Hualan Bio Main Business
    Table 126. Hualan Bio Latest Developments
    Table 127. CNBG Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 128. CNBG Human Immune Globulin Intravenous Product Offered
    Table 129. CNBG Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 130. CNBG Main Business
    Table 131. CNBG Latest Developments
    Table 132. Shanghai RAAS Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 133. Shanghai RAAS Human Immune Globulin Intravenous Product Offered
    Table 134. Shanghai RAAS Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 135. Shanghai RAAS Main Business
    Table 136. Shanghai RAAS Latest Developments
    Table 137. CBPO Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 138. CBPO Human Immune Globulin Intravenous Product Offered
    Table 139. CBPO Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 140. CBPO Main Business
    Table 141. CBPO Latest Developments
    Table 142. LFB Group Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 143. LFB Group Human Immune Globulin Intravenous Product Offered
    Table 144. LFB Group Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 145. LFB Group Main Business
    Table 146. LFB Group Latest Developments
    Table 147. BPL Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 148. BPL Human Immune Globulin Intravenous Product Offered
    Table 149. BPL Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 150. BPL Main Business
    Table 151. BPL Latest Developments
    Table 152. Sichuan Yuanda Shuyang Basic Information, Human Immune Globulin Intravenous Manufacturing Base, Sales Area and Its Competitors
    Table 153. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Product Offered
    Table 154. Sichuan Yuanda Shuyang Human Immune Globulin Intravenous Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
    Table 155. Sichuan Yuanda Shuyang Main Business
    Table 156. Sichuan Yuanda Shuyang Latest Developments
List of Figures
    Figure 1. Picture of Human Immune Globulin Intravenous
    Figure 2. Human Immune Globulin Intravenous Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Human Immune Globulin Intravenous Sales Growth Rate 2017-2028 (K Units)
    Figure 7. Global Human Immune Globulin Intravenous Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Human Immune Globulin Intravenous Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of IVIg Liquid
    Figure 10. Product Picture of IVIg Powder
    Figure 11. Global Human Immune Globulin Intravenous Sales Market Share by Type in 2021
    Figure 12. Global Human Immune Globulin Intravenous Revenue Market Share by Type (2017-2022)
    Figure 13. Human Immune Globulin Intravenous Consumed in Immunodeficiency
    Figure 14. Global Human Immune Globulin Intravenous Market: Immunodeficiency (2017-2022) & (K Units)
    Figure 15. Human Immune Globulin Intravenous Consumed in Autoimmune Disease
    Figure 16. Global Human Immune Globulin Intravenous Market: Autoimmune Disease (2017-2022) & (K Units)
    Figure 17. Human Immune Globulin Intravenous Consumed in Acute Infection
    Figure 18. Global Human Immune Globulin Intravenous Market: Acute Infection (2017-2022) & (K Units)
    Figure 19. Global Human Immune Globulin Intravenous Sales Market Share by Application (2017-2022)
    Figure 20. Global Human Immune Globulin Intravenous Revenue Market Share by Application in 2021
    Figure 21. Human Immune Globulin Intravenous Revenue Market by Company in 2021 ($ Million)
    Figure 22. Global Human Immune Globulin Intravenous Revenue Market Share by Company in 2021
    Figure 23. Global Human Immune Globulin Intravenous Sales Market Share by Geographic Region (2017-2022)
    Figure 24. Global Human Immune Globulin Intravenous Revenue Market Share by Geographic Region in 2021
    Figure 25. Global Human Immune Globulin Intravenous Sales Market Share by Region (2017-2022)
    Figure 26. Global Human Immune Globulin Intravenous Revenue Market Share by Country/Region in 2021
    Figure 27. Americas Human Immune Globulin Intravenous Sales 2017-2022 (K Units)
    Figure 28. Americas Human Immune Globulin Intravenous Revenue 2017-2022 ($ Millions)
    Figure 29. APAC Human Immune Globulin Intravenous Sales 2017-2022 (K Units)
    Figure 30. APAC Human Immune Globulin Intravenous Revenue 2017-2022 ($ Millions)
    Figure 31. Europe Human Immune Globulin Intravenous Sales 2017-2022 (K Units)
    Figure 32. Europe Human Immune Globulin Intravenous Revenue 2017-2022 ($ Millions)
    Figure 33. Middle East & Africa Human Immune Globulin Intravenous Sales 2017-2022 (K Units)
    Figure 34. Middle East & Africa Human Immune Globulin Intravenous Revenue 2017-2022 ($ Millions)
    Figure 35. Americas Human Immune Globulin Intravenous Sales Market Share by Country in 2021
    Figure 36. Americas Human Immune Globulin Intravenous Revenue Market Share by Country in 2021
    Figure 37. United States Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 38. Canada Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Mexico Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Brazil Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 41. APAC Human Immune Globulin Intravenous Sales Market Share by Region in 2021
    Figure 42. APAC Human Immune Globulin Intravenous Revenue Market Share by Regions in 2021
    Figure 43. China Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 44. Japan Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 45. South Korea Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 46. Southeast Asia Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 47. India Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 48. Australia Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Europe Human Immune Globulin Intravenous Sales Market Share by Country in 2021
    Figure 50. Europe Human Immune Globulin Intravenous Revenue Market Share by Country in 2021
    Figure 51. Germany Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 52. France Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 53. UK Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 54. Italy Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Russia Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Middle East & Africa Human Immune Globulin Intravenous Sales Market Share by Country in 2021
    Figure 57. Middle East & Africa Human Immune Globulin Intravenous Revenue Market Share by Country in 2021
    Figure 58. Egypt Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 59. South Africa Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 60. Israel Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Turkey Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 62. GCC Country Human Immune Globulin Intravenous Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Manufacturing Cost Structure Analysis of Human Immune Globulin Intravenous in 2021
    Figure 64. Manufacturing Process Analysis of Human Immune Globulin Intravenous
    Figure 65. Industry Chain Structure of Human Immune Globulin Intravenous
    Figure 66. Channels of Distribution
    Figure 67. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Human Immune Globulin Intravenous Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Human Immune Globulin Intravenous Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Human Immune Globulin Intravenous Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports